首页> 美国卫生研究院文献>Neuro-Oncology >O7.03IDH-1 MUTATED GLIOBLASTOMAS HAVE A LESS INVASIVE PHENOTYPE THAN IDH-1 WILD TYPE GLIOBLASTOMAS: A DIFFUSION TENSOR IMAGING STUDY
【2h】

O7.03IDH-1 MUTATED GLIOBLASTOMAS HAVE A LESS INVASIVE PHENOTYPE THAN IDH-1 WILD TYPE GLIOBLASTOMAS: A DIFFUSION TENSOR IMAGING STUDY

机译:与IDH-1野生型胶质母细胞瘤相比O7.03IDH-1突变的胶质母细胞瘤具有较少的侵入性表型:弥散张量成像研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTION: IDH-1 mutated glioblastomas are associated with a better prognosis than glioblastomas with wild type IDH-1. Most explanations for this improved prognosis is due to these tumours responding better to therapy. Recent work has suggested they have a different behaviour. Diffusion tensor imaging (DTI) is able to explore the invasive behaviour of glioblastomas and can identify a number of invasive phenotypes. Approximately 20% have a minimally invasive pattern that have improved survival. This study aims to look at differences in invasive behaviour in pre-operative GBMs with IDH-1 mutation status. METHODS: Patients with resectable glioblastomas were imaged at 3T with a protocol including DTI. The DTI data was decomposed into isotropic (p) and anisotropic (q) components and these abnormalities were outlined. The difference between these regions have been shown previously to be the region of invasion and was classified according to previously published classification. The tumours were resected and the IDH-1 status assessed using immunohistochemistry for the R132 mutation. RESULTS: 68 patients were studied with 9 IDH-1 mutated GBMs, and 57 with wild type IDH-1. All of the IDH-1 tumours exhibited minimally invasive DTI patterns. Only 5 (8%) of the IDH-1 negative tumours were minimally invasive, 14 (24%) had a localised invasive pattern and the majority 41 (69%) had a diffuse pattern of invasion. In all of the IDH-1 group there was the tumour surrounded by intact white matter as confirmed by diffusion tissue signature measurements. CONCLUSION: We have shown that IDH-1 mutated GBM have a different invasive behaviour compared to the non-mutated GBMs. This difference is seen at first presentation and is not related to response to therapy. This lack of invasion can help explain the better prognosis of this GBM subtype.
机译:简介:IDH-1突变的胶质母细胞瘤比野生型IDH-1的胶质母细胞瘤预后更好。这种改善预后的大多数解释是由于这些肿瘤对治疗的反应更好。最近的工作表明他们有不同的行为。扩散张量成像(DTI)能够探索胶质母细胞瘤的侵袭行为,并可以识别多种侵袭表型。大约20%的患者具有微创模式,可提高生存率。这项研究旨在探讨具有IDH-1突变状态的术前GBM的侵袭行为差异。方法:将可切除的胶质母细胞瘤患者在3T时使用包括DTI的协议进行成像。 DTI数据被分解为各向同性(p)和各向异性(q)分量,并概述了这些异常。这些区域之间的差异先前已显示为入侵区域,并根据先前发布的分类进行了分类。切除肿瘤并使用免疫组织化学对R132突变评估IDH-1状态。结果:68例患者接受了9个IDH-1突变的GBM,57例进行了野生型IDH-1的研究。所有IDH-1肿瘤均表现出微创DTI模式。 IDH-1阴性肿瘤中仅有5种(8%)为微创性,有14种(24%)具有局部性浸润型,大多数41种(69%)具有弥漫性浸润型。在所有IDH-1组中,肿瘤均被完整的白质所包围,这通过扩散组织特征测量得到了证实。结论:我们已经证明IDH-1突变的GBM与非突变的GBM相比具有不同的侵袭行为。这种差异在首次出现时就可见,与对治疗的反应无关。这种侵袭的缺乏可以帮助解释该GBM亚型的更好的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号